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Background: To determine whether saliva is a good means of evaluating concentrations of oxidative stress bio-
markers, analyzing the correlation between concentrations in saliva and in follicular tissue, and to compare bio-
marker concentrations in patients with one asymptomatic mandibular impacted third molar (MITM) (before ex-
traction) with a healthy control, and to determine how biomarkers are modified by extraction. 
Material and Methods: 80 patients with one asymptomatic MITM and 80 healthy controls were included. Saliva 
samples were collected from all subjects (before extraction in the study group) to evaluate Myeloperoxidase 
(MPO) and Malondialdehyde (MDA) concentrations. Follicular tissues were obtained during surgery to measure 
biomarkers. One month after extraction, saliva samples were collected to assess changes of oxidative stress. 
Results: Salivary MPO and MDA showed positive correlation with concentrations in follicular tissue (MPO: cor-
relation coefficient=0.72, p=0.025; MDA: =0.92, p=0.001). Patients with asymptomatic MITMs showed higher 
salivary concentrations of oxidative stress biomarkers than healthy control subjects, with statistical significance 
for both MPO (p<0.001) and MDA (p<0.001). One month after extraction, salivary biomarkers decreased signifi-
cantly in the study group (p<0.001). 
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Introduction
Among all the teeth, third molars are the most often 
impacted, constituting a major class of dental pathol-
ogy, not only because of the frequency of impaction and 
the variety of forms of presentation, but also because 
of the pathologies and events that impacted third mo-
lars (ITMs) often trigger (1). This is why ITM extrac-
tion is the most common intervention in oral surgery. 
The third molar erupts at an average age of 19.5-20.5 
years (17-19 years in the mandible and 17-21 in the up-
per maxilla) (2). As it is the last tooth to erupt, it can 
easily remain impacted or be displaced whenever there 
is insufficient space for it to erupt in the dental arch (1). 
In this way, anatomical and embryological character-
istics will determine the degree of impaction or erup-
tion. When third molars fail to erupt, they may generate 
some pathology. 
Mandibular impacted third molars (MITMs) are the 
most frequently impacted teeth mainly due to lack of 
adequate space in the lower jaw or some other barrier 
to their eruption trajectory (3). MITMs may remain as-
ymptomatic throughout an individual’s life but some-
times, different clinical pathologies or complications 
develop that can be classified as infectious, tumoral, 
mechanical, or nervous events (4).
With regard to indications for asymptomatic MITM ex-
traction, it is estimated that approximately 54% of MITMs 
are removed prophylactically despite the absence of symp-
toms and that some 30-40% are removed without valid 
indications (5). These data indicate that to date, consensus 
has not been reached as to the reasons for the prophylactic 
removal of asymptomatic MITMs (6). In 1979, the Nation-
al Institute of Dental and Craniofacial Research (NIDCR), 
a division of the US National Institutes of Health (NIH), 
hosted a Consensus Development Conference (7) on ITM 
extraction, but no clear agreement was reached regarding 
the prophylactic removal of asymptomatic ITMs. Recent 
trends in research have sought to rationalize this surgery, 
and multiple studies have set out to establish a uniform ap-
proach to diagnosis and indications for the prophylactic 
removal of asymptomatic ITMs. 
Nevertheless, in spite of numerous studies showing that 
MITM peri-coronal tissue may develop both cystic and 
neoplastic pathologies (8), the accepted norm is that 
only MITMs with a dental follicle (DF) presenting a 
radiological size over 2.5 mm (abnormal radiolucency), 
Conclusions: Salivary MPO and MDA are higher among patients with one asymptomatic MITM, but these levels 
decrease significantly one month after surgical extraction. The large decrease in oxidative stress biomarkers could 
justify third molar extraction despite the absence of symptoms.
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even though asymptomatic, constitutes a pathological 
risk justifying its prophylactic removal (9). In opposi-
tion to this convention, some researchers have per-
formed histological and immunohistochemical analyses 
of the dental follicles of asymptomatic MITMs, find-
ing immunoexpression of p63 (10) and Ki-67 (11), and 
observing signs of mucous cell prosoplasia, squamous 
metaplasia, but mainly, increased inflammatory activity 
indicating potential cellular proliferation in the odonto-
genic epithelia of the DF of the asymptomatic MITM.
In support of these indications of pathological risk, sev-
eral scientific papers have been published in recent years 
that show that the DFs of asymptomatic MITMs pres-
ent high concentrations of oxidative stress biomarkers 
(12-14) with increased reactive oxygen species (ROS). 
Among these oxidative stress biomarkers, Myeloperoxi-
dase (MPO) is an oxidative enzyme present in phago-
cytes. MPO can be released by activated neutrophils, 
monocytes, and macrophages and it is an essential part 
of the anti-microbial and inflammatory regulation sys-
tem. MPO is a heme enzyme that uses the oxidizing po-
tential of superoxide and hydrogen peroxide (H2O2) to 
convert chloride ions into hypochlorous acid and other 
ROS (15). Another is Malondialdehyde (MDA), a direct 
product of the action of oxygen free radicals on polyun-
saturated fatty acids in the cell membrane; uncontrolled 
production of lipid peroxides indicates damage to cell 
integrity (16).
So, chronic inflammatory activity deriving from the 
presence of asymptomatic MITMs and the increase of 
these oxidative stress biomarkers in the DF could be 
related with potential cellular proliferation in the odon-
togenic epithelium and so the possible development of 
epithelial tumors and odontogenic cysts. 
The primary aim of this study was to determine if sali-
vary MPO and MDA are increased in patients exhibit-
ing an asymptomatic MITM. The secondary objectives 
were: 1) to determine whether saliva is a good means 
of evaluating concentrations of oxidative biomarkers, 
2) to analyze the correlation between concentrations of 
oxidative stress biomarkers in saliva and in follicular 
tissue, 3) to compare concentrations of oxidative stress 
biomarkers in saliva in patients with MITM (before 
extraction) with a healthy control, 4) and to determine 
how concentrations of oxidative stress biomarkers in sa-
liva are modified by extraction.
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Material and Methods
-Recruitment and patient characteristics
The study protocol was approved by the University of 
Murcia Ethics Committee and was carried out between 
May 2017 and February 2018 at the University Dental 
Clinic (University of Murcia, Murcia, Spain). Subjects 
were treated according to guidelines established by the 
declaration of Helsinki for medical research involving 
human subjects. All subjects provided their informed 
consent to participate. The entire protocol (clinical, sur-
gery, and laboratory) was carried out by a single clini-
cian.
Inclusion criteria in the study group were as follows: 
patients with a single asymptomatic MITM with no 
signs of chronic inflammation deriving from periodon-
tal disease (necrotizing periodontitis, periodontitis as a 
manifestation of systemic disease or periodontitis) and/
or inflammatory mucosal diseases (aphthous inflamma-
tion, vitamin deficiency inflammation, viral/bacterial/
fungal inflammation, physics/chemical/radiological in-
flammation, autoimmune/reumathological/syndromic 
inflammation); medically healthy subjects not in receipt 
of any drugs for 30 days before surgery. 
For the control group the inclusion criteria were: healthy 
subjects with no impacted tooth (absence of asymptom-
atic MITM). 
An exclusion criterion for both groups was the ingestion 
of any antioxidant-based dietary supplement.
None of the patients who fulfilled the inclusion criteria 
and were invited to take part in the trial refused to do 
so. A total of 80 patients with one asymptomatic MITM 
and 80 healthy control subjects were included in this 
prospective clinical study. 
Before surgery, patients’ sociodemographic data were 
registered, as well as their status regarding smoking 
(non-smoker, ≤10, 11-20, >20) and alcohol (yes or no) 
consumption, tooth brushing (1/day, 2/day, ≥3/day), 
probing depth (in millimeters). The characteristics and 
level of surgical difficulty presented by the asymptom-
atic MITM (study group) were assessed by radiologi-
cal analysis using orthopantomographs, according to 
Alemany-Martinez et al., (17).
-Concentrations of salivary MPO and MDA 
All saliva samples (n=160 at baseline: n=80 study group; 
n=80 control group; n=80 study group samples 1 month 
after surgical IMTM extraction) were collected under 
the same conditions (first thing in the morning, instruct-
ing subjects not to eat or drink for 90 minutes before 
sample collection). Patients were placed in a relaxed po-
sition, looking downwards and dropping the saliva into 
a test tube with a funnel. At least 5 ml of non-stimulated 
saliva was obtained from each subject and collected in 
test tubes. The samples were protected from light and 
kept at 4ºC for under 30 minutes before processing. 
Then the samples were centrifuged at 2,500 g for 10 
minutes and aliquot saliva samples were snap-frozen in 
liquid nitrogen and stored at -80ºC for less than 30 days. 
Trace element-free tubes were used in order to optimize 
sample stability and minimize self-generated processes 
of lipid peroxidation. Saliva samples were analyzed in a 
single bath after one thaw cycle.  
Salivary MPO concentration was measured by en-
zyme-linked immunosorbent assay (ELISA kit, Im-
mundiagnostik, Bensheim, Germany), following the 
manufacturer’s instructions (detection level 1.6 ng/ml, 
coefficient of intra-assay variation 4.5% and coefficient 
of inter-assay variation 13.5%). Salivary MPO levels 
were expressed in ng/ml.
Salivary MDA concentration was measured by high-
performance liquid chromatography (HPLC) after reac-
tion with thiobarbituric acid (TBA) to form MDA-TBA 
adduct (18). The adduct was eluted from the column 
with methanol-phosphate buffer and quantified by spec-
trophotometry at 532 nm. Salivary MDA levels were 
expressed in µmol/l.
-Surgical procedure
The extraction of impacted third molars was standard-
ized as much as possible. All surgical interventions 
were performed by a single clinician under local an-
esthesia (articaine 1:100.000), in the normal course of 
practice and under similar conditions. After removal of 
the MITMs, the remnants of pericoronal tissue were cu-
retted from the bony socket and placed in a deep freeze 
(-80ºC for less than 30 days).
In all cases, the postoperative medication prescribed 
was amoxicillin 50 mg every 8 h for 7 days (in cases 
of penicillin allergy, 300 mg clindamycin was admin-
istered every 8 h) and ibuprofen 600 mg every 8 h for 
3 days.
-Concentration of MPO and MDA levels in follicular 
tissue 
Follicular tissue samples were analyzed (after one thaw 
cycle) for MPO and MDA oxidative stress biomarkers 
and inflammation in a single bath (18,19).
For quantification of MPO levels in follicular tissue, the 
tissue was processed using the technique described by 
Souza et al., (20). The samples were homogenized in 
two volumes of buffer solution for freezing (0.1 mol/l of 
NaCL; 20 mmol/l NaPO4; 15 mmol/l Na EDTA) at pH 
4.7 and centrifuged at 0.8 g for 15 minutes. The pellets 
then underwent hypotonic lysis (900 µl of 0.2% NaCL 
solution for 30 seconds and then afterwards an equiva-
lent volume containing 1.6% NaCL and 5% glucose 
was added). After centrifuging a second time, the pel-
lets were resuspended in 50 mmol/l of NaPO4 buffer at 
pH 5.4, containing 0.5% hexadecyltrimethylammonium 
bromide, and again rehomogenized and centrifuged at 
9.3 g for 15 minutes at 4ºC. MPO activity in the resus-
pended pellets was quantified by spectrophotometry, to 
measure changes in absorbance at 450 nm using a tet-
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ramethylbenzidine solution (1.6 mmol/l) and hydrogen 
peroxide (0.5 mmol/l). The concentration of MPO in 
follicular tissue was expressed in nmol/g of tissue.
For quantification of MDA levels in follicular tissue, 
the tissue was processed using the technique described 
by Araújo et al., (21). Samples were homogenized (0.25 
ml of 10% follicular tissue prepared in 0.15 mol/l KCL) 
and added to a thiobarbituric acid solution (1.5 ml of 1% 
H3PO4 and 500 µl of 0.6% thiobarbituric acid, both in 
aqueous solution), placing the sample in a water bath 
and heating to 100ºC for 45 minutes. Afterwards, 2 
ml of n-butanol PA was added and the samples were 
homogenized and then centrifuged at 40.816 g for 15 
minutes at 4ºC. The absorbance of the butanol layer was 
measured at 520 nm (A1) and 535 nm (A2). The MDA 
concentration was calculated as the difference between 
A2 and A1. The concentration of MDA in follicular tis-
sue was expressed in nmol/g of tissue.
-Statistical analysis
Data were analyzed using the SPSS 20.0 statistics pro-
gram (SPSS® Inc, Chicago, IL, USA). A descriptive 
study was made of each variable. The Kolmogorov-
Smirnov normality test and Levene’s homogeneity of 
variance test were applied; the data showed normal dis-
tribution and so were analyzed using parametric tests. 
Associations between the different qualitative variables 
were studied using Pearson’s chi-squared test. Asso-
ciations between different quantitative variables were 
studied using Student’s t-test for two related samples. 
Pearson’s correlation coefficient was used to evalu-
ate the correlation between saliva and follicular tissue 
concentrations of MPO and MDA in the study group 
(patients with MITMs). Statistical significance was ac-
cepted for p≤0.05.
Results
A total of 80 patients with one asymptomatic MITM 
(40 men and 40 women with a mean age of 25.31 ± 4.75 
years) and 80 healthy control subjects (40 men and 40 
females with a mean age of 25.74 ± 6.13 years) were 
included in this prospective clinical study. Both groups 
were homogenous with regard to demographic char-
acteristics, smoking, dental hygiene, and periodontal 
health assessed by probing depth (Table 1).
As for the clinical and surgical characteristics of as-
ymptomatic MITMs, of the 80 MITMs, 48 (60%) were 
on the right side and 32 on the left (40%). After radio-
logical analysis using orthopantomographs, 60% were 
considered as presenting minimal surgical difficulty, 
compared with 20% with moderate difficulty, and 20% 
with maximum difficulty. In 50% of cases, it was nec-
essary to perform crown sectioning, and in 30% root 
sectioning too (Table 2). 
Determining whether saliva offers a good means of 
evaluating oxidative stress biomarker concentrations 
by analyzing the correlation with samples obtained 
directly from dental follicular tissue, it was found that 
concentrations of salivary MPO and MDA showed a 
strong positive correlation to the biomarker concen-
trations measured in follicular tissue (correlation co-
efficient=0.72, p=0.025 for MPO; correlation coeffi-
cient=0.92, p=0.001 for MDA).
When concentrations of oxidative stress biomarkers 
were compared between patients with one asymptom-
 
Characteristics                                           Group with MITM*       Group without MITM       p-value 
                                                                                (n=80)                                (n=80)                             
  
Age: mean ± SD**                                              25.31 ± 4.75                        25.74 ± 6.13                0.625                 
 
Sex: n (%)                                                                                                                                          1.000       
   Male                                                                   40 (50.00)                          40 (50.00)                                                  
   Female                                                                40 (50.00)                          40 (50.00)    
    
Smoking behavior: n (%)                                                                                                               0.818                                                                                                         
   Non-smoker                                                        31 (38.75)                          36 (45.00)                                                                                             
   ≤ 10                                                                      8 (10.00)                             8 (10.00)  
   11-20                                                                  25 (31.25)                           20 (25.00)     
   > 20                                                                    16 (20.00)                           16 (20.00)    
 
Tooth brushing: n (%)                                                                                                                      0.606                                                   
   1/day                                                                     8 (10.00)                            8 (10.00)                                                                                     
   2/day                                                                   38 (47.50)                          32 (40.00)        
   ≥ 3/day                                                                34 (42.50)                          40 (50.00)       
 
Probing depth (mm): mean ± SD                       2.71 ± 0.57                         2.66 ± 0.55                0.649                                          
 
 
Table 1: Homogeneity of the study groups in terms of demographic characteristics, smoking habit, dental hygiene, and prob-
ing depth (Student’s t and Pearson’s χ2 tests).
* MITM = mandibular impacted third molar; ** SD = standard deviation 
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Clinical and surgical characteristics                                                         Impacted third molars 
                                                                                                                                    (n=80) 
 
Localization: n (%)   
   3.8                                                                                                                         48 (60.00)   
   4.8                                                                                                                         32 (40.00)                                                            
 
Maximum interincisal oral opening (cm): mean ± SD*                                      5.40 ± 0.66                                                                                                                                                                                                                                      
          
Surgical difficulty according to Alemany-Martínez et al., (x): n (%)  
   Minimum                                                                                                              48 (60%)                                              
   Moderate                                                                                                               16 (20%)    
   Very difficult                                                                                                        16 (20%)   
 
Crown sectioning: n (%) 
   Yes                                                                                                                        40 (50%)                                                                                           
   No                                                                                                                         40 (50%)   
 
Root sectioning: n (%) 
   Yes                                                                                                                        24 (30%)                                                                                       
   No                                                                                                                         56 (70%) 
 
Temporary paresthesia: n (%) 
   Yes                                                                                                                          4 (5%)        
   No                                                                                                                         76 (95%)     
  
  
Table 2: Clinical and surgical characteristics of impacted third molars.
* SD = standard deviation
atic MITM and healthy control subjects, study group 
patients with an asymptomatic MITM showed higher 
concentrations than control subjects, with statistically 
significant differences for both MPO (p<0.001) and 
MDA (p<0.001) (Table 3) (Fig. 1).
Lastly, when assessing whether oxidative stress bio-
markers are modified after surgical third molar extrac-
tion, it was found that one month after extraction, sali-
vary biomarkers decreased significantly for both MPO 
(p<0.001) and MDA (p<0.001) (Table 4) (Fig. 2).
Discussion
Among all the teeth, MITMs are the most often impacted, 
making MITM extraction the most common intervention 
in oral surgery (22). Although it may remain asymp-
tomatic throughout an individual’s life, the MITM often 
presents various types of pathological conditions such as 
pericoronaritis, swelling, odontogenic cysts or tumors, 
 
MPO and MDA                                 Group with MITM*       Group without MITM       p-value 
                                                                        (n=80)                               (n=80)                             
 
MPO (ng/ml): mean ± SD**                   311.90 ± 41.14                   202.60 ± 18.19              <0.001                            
                        
MDA (µmol/l): mean ± SD                        0.45 ± 0.06                          0.33 ± 0.11               <0.001                                                                                                                                                                                                                                                                                                  
    
  
Table 3: Comparison of saliva concentration of MPO and MDA between study groups, before the surgical extraction in 
group with impacted third molar (Student t test).
* MITM = mandibular impacted third molar; ** SD = standard deviation
bone loss, or root resorption of the adjacent teeth, which 
will be accompanied by the interruption of normal oral 
functionality, reducing the patient’s quality of life (23).
Prophylactic extraction of asymptomatic MITMs contin-
ues to be a controversial procedure due to the unpredict-
able nature of possible future complications, events and 
pathologies (24), weighed against the risks associated 
with extraction procedures such as pain, inflammation, 
bleeding, trismus, dry socket, dehiscence during primary 
wound healing, and different degrees of dysesthesia or 
paresthesia caused by damage to the inferior alveolar 
nerve. The percentage of MITMs that undergo prophy-
lactic surgical extraction is difficult to estimate, although 
a 2003 study by Song et al., (25) estimated that in the 
United Kingdom between 20% and 40% of MITM ex-
tractions were preventative. Meanwhile, the detractors of 
prophylactic extractions argue against surgery because 
the probability of future complications is low (26).
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Fig. 1: Comparison of oxidative stress biomarkers concentration in saliva between study 
groups (patients with or without MITM). A: MPO. B: MDA.
 
MPO and MDA                       Before surgical extraction (day 0)    1 month after surgical extraction      p-value 
                                                                        (n=80)                                              (n=80)                             
 
MPO (ng/ml): mean ± SD*                      311.90 ± 41.14                                 210.88 ± 9.30                             <0.001                            
                        
MDA (µmol/l): mean ± SD                          0.45 ± 0.06                                       0.35 ± 0.06                             <0.001                                                                                                                                                                                                                                                                                                  





Table 4: Comparison of saliva concentration of MPO and MDA in group with impacted third molar, before and one month after surgical 
extraction (Student t test).
* SD = standard deviation
At the present time, only MITMs with a DF of a ra-
diological size of 2.5 mm (even though asymptom-
atic) constitutes a risk of possible future evolution of 
both cystic or neoplastic pathology, and so should be 
extracted. Esen et al., (27) performed a retrospective 
histopathological study of the DFs of 83 ITMs, 48 of 
which presented symptoms, while 35 remained asymp-
tomatic, observing that the DFs of asymptomatic ITMs 
also presented neutrophilic and mixed inflammation, 
odontogenic remnants, mesenchymal myxoid degenera-
tion, and squamous metaplasia. The authors concluded 
that delaying ITM extraction can lead to further patho-
logical changes in DFs and increased severity of the in-
flammation, and so the radiological dimensions of the 
DF should not be used as the single criterion to assess 
pathological changes around the impacted third molar. 
Similar data were published by Cabbar et al., (11) who 
made a histological and immunohistochemical study of 
a total of 59 DFs of asymptomatic MITMs, finding that 
histologic examination showed that 11.9% presented 
mucous cell prosoplasia, 55.9% squamous metaplasia, 
15.3% glandular epithelium, and 33.9% inflammation. 
Immunohistochemical analysis found high Ki-67 im-
munoexpression. In addition to these data in support of 
prophylactic extraction of asymptomatic MITMs, other 
immunohistochemical studies based on the immunoex-
pression of p63 (10) and Ki-67 (11) have observed signs 
of mucous cell prosoplasia, squamous metaplasia, and 
increased inflammatory activity, indicating potential 
cell proliferation in the odontogenic epithelia of the DFs 
of asymptomatic MITMs.
Numerous studies have been published that have used 
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Fig. 2: Comparison of oxidative stress biomarkers concentration in saliva in group with 
MITM, before and one month after surgical extraction. A: MPO. B: MDA.
oxidative stress biomarkers as indicators of various oral 
pathologies such as odontogenic cysts, inflammatory 
diseases of the oral mucosa, saliva gland pathology, or 
oral cancer (28). Chronic inflammatory activity derived 
from the presence of asymptomatic MITMs and the in-
crease in these oxidative stress biomarkers in DFs could 
be related to potential cellular proliferation in the odon-
togenic epithelia, and so the possible development of 
epithelial tumors and odontogenic cysts. In 2011, Tekin 
et al., (14) analyzed MDA levels in a total of 40 DFs 
corresponding to asymptomatic MITMs, comparing 
these levels with 40 samples taken from healthy gingi-
val tissue; higher MDA levels were found in the DFs of 
MITMs with statistically significant difference. 
To date only one published work has made a longitu-
dinal study of the decrease in inflammation and MDA 
following the extraction of ITMs, using blood serum 
samples (29), but the possible decrease in salivary MPO 
and MDA after extraction has not been investigated. 
For this reason, the present study set out to determine 
whether saliva analysis provides a reliable means of 
evaluating oxidative stress biomarker concentrations 
by analyzing its correlation with samples taken directly 
from follicular tissue, and to compare biomarker con-
centrations in patients with one asymptomatic MITM 
against a group of healthy control subjects, to find out if 
biomarker levels undergo modification as a result of ex-
traction. Saliva samples are easily collected and so offer 
a simple means of monitoring MPO and MDA in dif-
ferent oral inflammatory pathologies (30). The present 
results of saliva analysis indicated a high positive corre-
lation with biomarker concentrations measured directly 
in follicular tissue samples, a finding that allowed us to 
move forwards to fulfill the study’s ultimate objective.   
Comparing MPO and MDA concentrations in patients 
presenting one asymptomatic MITM with healthy con-
trol group subjects, it was found that MITM patients 
showed higher salivary concentrations of oxidative 
stress biomarkers than subjects without ITMs for both 
MPO (p<0.001) and MDA (p<0.001). Tekin et al., (14) 
obtained similar results. These authors analyzed MDA 
levels in a total of 40 DFs corresponding to asymptom-
atic MITMs comparing levels against 40 samples taken 
from control subjects presenting healthy gingival tissue; 
higher levels of MDA in DFs were found with statis-
tically significant difference (p<0.001). However, the 
study did not ensure that the control subjects did not 
have impacted teeth; in fact, the healthy gingival tissue 
was obtained from the same patient group with asymp-
tomatic MITMs.
Lastly, to determine whether biomarker concentra-
tions are modified as a result of MITM extraction, one 
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month after surgery salivary biomarkers were found to 
decrease with statistically significant differences for 
both MPO (p<0.001) and MDA (p<0.001). The pres-
ent study’s main limitation was the impossibility of 
comparing the results with other research, as no other 
work has made a longitudinal study of salivary levels 
of MPO y MDA and whether or not they decrease af-
ter extracting a single MITM. Nevertheless, Graziani 
et al., (29) published a study that confirmed decreases 
in white blood cells, C-reactive protein, fibrinogen, and 
also MDA, in blood samples 3 months after the surgical 
extraction of MITMs in 40 patients, although it should 
be noted that the MITMs were not asymptomatic but 
presented recurrent pericoronaritis, caries, orthodontic 
disorders, or pathological damage to the second molars.
In conclusion, saliva provides a good means of evaluat-
ing concentrations of oxidative stress biomarkers. Sali-
vary levels of MPO and MDA are higher in patients with 
one asymptomatic MITM, but these levels decrease sig-
nificantly 1 month after surgical extraction. The large 
decrease in oxidative stress biomarkers observed in the 
present study could justify the surgical extraction of as-
ymptomatic MITMs, although further clinical research 
is required to confirm this finding.    
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